Human NKp44 PharmaGenie ELISA Kit (SBRS0926)

Profiling of natural killer (NK) cell activation through soluble receptor measurement is a growing need in tumor immunology, viral pathogenesis, and transplant research. NKp44 (NCR2/CD336) is one of the three natural cytotoxicity receptors selectively expressed on activated NK cells, where it triggers effector responses via an ITAM-bearing signalling adaptor. The Assay Genie Human NKp44 PharmaGenie ELISA Kit delivers an in vitro, plate-based immunoassay for quantifying this analyte across human cell culture supernatant and blood-derived research samples, supplied in a 96 assays format. Each kit includes a microplate pre-coated with capture antibody, lyophilized recombinant standards, biotinylated detection reagent, and streptavidin-HRP reagents. Researchers commonly pair this kit with ELISA quantification of NKp30 and NKp46 to monitor natural cytotoxicity receptor repertoire changes during immunotherapy, viral challenge, or reproductive immunology studies.